2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

653. Multiple Myeloma: Clinical and Epidemiological: Poster II

Program: Poster Abstract Session
Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Imaging, Molecular Testing, Omics Technologies, Clinical Procedures, Profiling, Treatment Considerations, Combination Therapy, Supportive Care, Therapy Sequence, Biological Therapies, Antibody Therapy, Transplantation, Bispecific Antibody Therapy, (CAR)-T Cell Therapies, Monoclonal Antibody Therapy, Adverse Events, Artificial Intelligence (AI), Machine Learning, Natural Language Processing, Biological Processes, Genomics, Microbiome, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Patient Safety, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Diseases, Bleeding and Clotting, Platelet Disorders, Thromboembolism, Thrombocytopenias, Immunology, Lymphoid Malignancies, Lymphomas, Plasma Cell Disorders, Myeloid Malignancies, Measurable Residual Disease, B Cell Lymphoma, Indolent Lymphoma, Research, Translational Research, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Survivorship, Study Population, Human, Adult, Elderly
PAPER

4003 The prognostic value of CT-derived body composition indices in patients with newly diagnosed multiple myeloma

Ioannis Ntanasis-Stathopoulos, MD, Ionas Papasotiriou2, Marina Kapsali3, Sotirios Manganas4, Kalliopi-Anna Poulia5, Artemis Galani6, Efstathios Kastritis, MD7, Maria Gavriatopoulou, MD8, Lia-Angela Moulopoulos9, Meletios-Athanasios (Thanos) C. Dimopoulos, MD10, Vassilis Koutoulidis11, Evangelos Terpos, MD12
1 National and Kapodistrian University of Athens, Athens, Greece
2 National and Kapodistrian University of Athens, Athens, Greece
3 National and Kapodistrian University of Athens, Athens, Greece
4 National and Kapodistrian University of Athens, Athens, Greece
5 Agricultural University of Athens, Athens, Greece
6 National and Kapodistrian University of Athens, Athens, Greece
7 National and Kapodistrian University of Athens, Athens, Greece
8 National and Kapodistrian University of Athens, Athens, Greece
9 National and Kapodistrian University of Athens, Athens, Greece
10 National and Kapodistrian University of Athens, Athens, Greece
11 National and Kapodistrian University of Athens, Athens, Greece
12 National and Kapodistrian University of Athens, Athens, Greece

Introduction: Body composition is a key element of health, with strong evidence supporting its role in disease outcome and survival for many types of cancer, especially solid tumors. Higher muscle and lower fat mass have been found to be associated with beneficial outcomes in patients diagnosed with cancer, while some studies have shown a negative impact of sarcopenia and central adiposity in hematological malignancies. However, there is still lack of evidence regarding the prognostic role of body composition elements in multiple myeloma (MM). Therefore, we aimed to examine the association between body composition indices, derived from routinely performed whole body low-dose computed tomography (WBCT) at diagnosis and survival in patients with MM.

 

Methods: This retrospective study included 200 consecutive patients with newly diagnosed MM (NDMM), who had undergone low-dose WBCT, as part of their initial work-up before receiving first line systemic therapy. Images at the L3 vertebra level where retrieved manually and body composition was assessed using the Quantib Body Composition software (Quantib Body Composition, version 0.2.1, DeepHealth, Rotterdam, the Netherlands), an online artificial intelligence-driven platform for automated tissue segmentation of CT-derived images. The skeletal muscle index (SMI), subcutaneous adipose tissue index (SATI), visceral adipose tissue index (VATI), were estimated alongside their ordinal variables based on sex-specific tertiles. Also, using a standardized multi-segment ROI approach, liver attenuation and its sex-specific tertiles were measured from WBCT, as a surrogate of splanchnic and visceral organ-specific adiposity. Progression-free survival (PFS) and overall survival (OS) were the main outcomes.

 

Results: After adjusting for age, sex, performance status, R-ISS and autologous stem cell transplantation (ASCT), multivariate Cox regression analysis showed that patients in the highest tertile of SMI had significantly lower mortality than those in the lowest tertile (HR:0.40, 95%CI:0.19–0.86, p=0.019). In addition, patients in the second and third tertiles of liver attenuation had significantly lower mortality risk compared with those in the first tertile (HR:0.41, 95%CI:0.22–0.75, p=0.004; HR:0.53, 95%CI:0.29–0.94, p=0.030, respectively). However, no significant associations were found between body composition indices and PFS in the multivariate analysis. Further analysis showed that higher SATI was associated with higher mortality risk after adjusting for SMI (HR:1.01, 95%CI:1.00–1.02, p=0.005). Since most available evidence regarding body composition and survival in MM exists for patients undergoing ASCT, a subgroup analysis was performed separately in patients who did not undergo ASCT. The results of this analysis showed that after adjusting for all confounders, non-ASCT patients with MM at the highest tertile of SMI had significantly lower risk of mortality than those at the lowest tertile (HR: 0.43, 95%CI: 0.19 – 0.97, p= 0.041).

 

Conclusion: The results of this study suggest that muscle mass-related indices and liver adiposity are significant predictors of survival in patients with NDMM. The estimation of these indices from routinely performed WBCT strengthens their clinical usefulness for baseline stratification of patients with NDMM.

Ioannis Ntanasis-Stathopoulos, MD: No relevant conflicts of interest to declare.